Search Keyword:


Search option:


IID00366
UniprotP17612
ProteincAMP-dependent protein kinase catalytic subunit alpha
GenePRKACA
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
351
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 1-351 Hetero dimer : IID50121Complex
 Evidence X-RAY 5uzk A Reference
       Region 5uzk A 1-14 disorder
       Region 5uzk A 15-351 order
Seq 1-351 Hetero dimer : IID00349Complex
 Evidence X-RAY 4wb8 A Reference
       Region 4wb8 A 16-351 order
 Evidence X-RAY 4wb6 B Reference
       Region 4wb6 B 2-8 disorder
       Region 4wb6 B 9-351 order
 Evidence X-RAY 4wb6 A Reference
       Region 4wb6 A 2-13 disorder
       Region 4wb6 A 14-351 order
 Evidence X-RAY 4wb5 A Reference
       Region 4wb5 A 2-13 disorder
       Region 4wb5 A 14-351 order
 Evidence X-RAY 3vqh A Reference
       Region 3vqh A 1-4 disorder
       Region 3vqh A 5-351 order
 Evidence X-RAY 4ujb A Reference
       Region 4ujb A 1-4 disorder
       Region 4ujb A 5-351 order
 Evidence X-RAY 4uja A Reference
       Region 4uja A 1-13 disorder
       Region 4uja A 14-351 order
 Evidence X-RAY 4uj9 A Reference
       Region 4uj9 A 1-10 disorder
       Region 4uj9 A 11-351 order
 Evidence X-RAY 4uj2 A Reference
       Region 4uj2 A 1-14 disorder
       Region 4uj2 A 15-351 order
 Evidence X-RAY 4uj1 A Reference
       Region 4uj1 A 1-14 disorder
       Region 4uj1 A 15-351 order
 Evidence X-RAY 3poo A Reference
       Region 3poo A 1-14 disorder
       Region 3poo A 15-319 order
       Region 3poo A 320-323 disorder
       Region 3poo A 324-351 order
 Evidence X-RAY 3p0m A Reference
       Region 3p0m A 1-14 disorder
       Region 3p0m A 15-351 order
 Evidence X-RAY 3oxt A Reference
       Region 3oxt A 1-14 disorder
       Region 3oxt A 15-351 order
 Evidence X-RAY 3owp A Reference
       Region 3owp A 1-15 disorder
       Region 3owp A 16-351 order
 Evidence X-RAY 3ovv A Reference
       Region 3ovv A 1-14 disorder
       Region 3ovv A 15-351 order
 Evidence X-RAY 3oog A Reference
       Region 3oog A 1-16 disorder
       Region 3oog A 17-351 order
 Evidence X-RAY 3nx8 A Reference
       Region 3nx8 A 1-15 disorder
       Region 3nx8 A 16-351 order
 Evidence X-RAY 5n23 A Reference
       Region 5n23 A 1-8 disorder
       Region 5n23 A 9-319 order
       Region 5n23 A 320-325 disorder
       Region 5n23 A 326-351 order
 Evidence X-RAY 3mvj E Reference
       Region 3mvj E 1-15 disorder
       Region 3mvj E 16-351 order
 Evidence X-RAY 3mvj B Reference
       Region 3mvj B 1-15 disorder
       Region 3mvj B 16-318 order
       Region 3mvj B 319-332 disorder
       Region 3mvj B 333-351 order
 Evidence X-RAY 3mvj A Reference
       Region 3mvj A 1-15 disorder
       Region 3mvj A 16-351 order
 Evidence X-RAY 3l9n A Reference
       Region 3l9n A 1-14 disorder
       Region 3l9n A 15-317 order
       Region 3l9n A 318-320 disorder
       Region 3l9n A 321-351 order
 Evidence X-RAY 3l9m B Reference
       Region 3l9m B 1-13 disorder
       Region 3l9m B 14-351 order
 Evidence X-RAY 3l9m A Reference
       Region 3l9m A 1-11 disorder
       Region 3l9m A 12-351 order
 Evidence X-RAY 3l9l B Reference
       Region 3l9l B 1-12 disorder
       Region 3l9l B 13-351 order
 Evidence X-RAY 3l9l A Reference
       Region 3l9l A 1-11 disorder
       Region 3l9l A 12-351 order
 Evidence X-RAY 5bx7 A Reference
       Region 5bx7 A 1-5 disorder
       Region 5bx7 A 6-350 order
 Evidence X-RAY 5bx6 A Reference
       Region 5bx6 A 1-5 disorder
       Region 5bx6 A 6-351 order
 Evidence X-RAY 3amb A Reference
       Region 3amb A 1-3 disorder
       Region 3amb A 4-320 order
       Region 3amb A 321-325 disorder
       Region 3amb A 326-351 order
 Evidence X-RAY 3ama A Reference
       Region 3ama A 1-1 disorder
       Region 3ama A 2-320 order
       Region 3ama A 321-325 disorder
       Region 3ama A 326-351 order
Seq 1-351 Monomer :
 Evidence X-RAY 5j5x A Reference
       Region 5j5x A 1-9 disorder
       Region 5j5x A 10-351 order
 Evidence X-RAY 5izj B Reference
       Region 5izj B 1-14 disorder
       Region 5izj B 15-321 order
       Region 5izj B 322-331 disorder
       Region 5izj B 332-351 order
 Evidence X-RAY 5izj A Reference
       Region 5izj A 1-14 disorder
       Region 5izj A 15-319 order
       Region 5izj A 320-326 disorder
       Region 5izj A 327-351 order
 Evidence X-RAY 5izf A Reference
       Region 5izf A 1-13 disorder
       Region 5izf A 14-351 order
 Evidence X-RAY 3agm A Reference
       Region 3agm A 1-12 disorder
       Region 3agm A 13-351 order
 Evidence X-RAY 3agl B Reference
       Region 3agl B 1-14 disorder
       Region 3agl B 15-351 order
 Evidence X-RAY 3agl A Reference
       Region 3agl A 1-10 disorder
       Region 3agl A 11-351 order
 Evidence X-RAY 4ae9 B Reference
       Region 4ae9 B 16-319 order
       Region 4ae9 B 320-331 disorder
       Region 4ae9 B 332-351 order
 Evidence X-RAY 4ae9 A Reference
       Region 4ae9 A 16-322 order
       Region 4ae9 A 323-337 disorder
       Region 4ae9 A 338-351 order
 Evidence X-RAY 4ae6 B Reference
       Region 4ae6 B 16-16 disorder
       Region 4ae6 B 17-319 order
       Region 4ae6 B 320-331 disorder
       Region 4ae6 B 332-351 order
 Evidence X-RAY 4ae6 A Reference
       Region 4ae6 A 16-319 order
       Region 4ae6 A 320-337 disorder
       Region 4ae6 A 338-351 order
Seq 15-351 Hetero dimer :
 Evidence X-RAY 2gu8 A Reference
       Region 2gu8 A 15-351 order
Seq 16-351 Hetero dimer : IID00349Complex,IID00446Complex
 Evidence X-RAY 4wb7 A Reference
       Region 4wb7 A 16-351 order
Seq 16-351 Hetero dimer : IID00349Complex,IID00446Complex
 Evidence X-RAY 4wb7 B Reference
       Region 4wb7 B 16-351 order
Seqphosphorylation
    331-331 Phosphotyrosine
    198-198 Phosphothreonine; by PDPK1
    140-140 Phosphoserine
    196-196 Phosphothreonine
    49-49 Phosphothreonine
    11-11 Phosphoserine; by autocatalysis
    339-339 Phosphoserine
 
Prediction
NeProc
Disorder 1-13,336-341
Order 14-32,38-335,342-351
ProS 336-341
AlphaFold
Disorder 1-13
Order 14-351
Pfam Hmmer
PF00069 44-298 4.4e-93
Function
Function in SwissProt
Phosphorylates a large number of substrates in the cytoplasm and the nucleus (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, SOX9 and VASP (PubMed:15642694, PubMed:15905176, PubMed:16387847, PubMed:17333334, PubMed:17565987, PubMed:17693412, PubMed:18836454, PubMed:19949837, PubMed:20356841, PubMed:21085490, PubMed:21514275, PubMed:21812984). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed:21423175). RORA is activated by phosphorylation (PubMed:21514275). Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts (PubMed:19949837). Involved in chondrogenesis by mediating phosphorylation of SOX9 (By similarity). Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP (PubMed:15642694, PubMed:20356841). Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated (PubMed:17333334). RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+) (PubMed:17693412). PSMC5/RPT6 activation by phosphorylation stimulates proteasome (PubMed:17565987). Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation (PubMed:15905176). NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding (PubMed:15642694). Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis. Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation (By similarity). May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT) (By similarity). Phosphorylates APOBEC3G and AICDA (PubMed:16387847, PubMed:18836454). Phosphorylates HSF1; this phosphorylation promotes HSF1 nuclear localization and transcriptional activity upon heat shock (PubMed:21085490).
Isoform 2
Phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation.
Biological Process
See also
Diagram with PDB data
CFTR/YWHAZCrystal structure of human 14-3-3 zeta in complex with CFTR R-domain peptide pS753-pS768
CREB1/CRBBP/KMT2AAllosteric communication in the KIX domain proceeds through dynamic re-packing of the hydrophobic core
POLD3/PCNACrystal structure of hPCNA bound to residues 452-466 of the DNA polymerase-delta-p66 subunit
AANAT/YWHAZCRYSTAL STRUCTURE OF THE 14-3-3 ZETA:SEROTONIN N-ACETYLTRANSFERASE COMPLEX